logo

Centrum Wsparcia Badań Klinicznych – CWBK (Clinical Trials Support Center) of the National Institute of Geriatrics, Rheumatology and Rehabilitation (NIGRiR) is a site conducting clinical trials in fields such as: rheumatology, immunology, neurology, cardiology, orthopedics, rehabilitation, pulmonology, and dermatology. In our modern center, clinical trials are conducted at the highest standard and with maximum comfort for patients.

CWBK, as a highly specialized unit, conducts clinical trials for patients from all over Poland, with particular attention to those who present diagnostic and therapeutic challenges, for whom participation in clinical trials may be the only chance to improve health, slow disease progression, or achieve remission.

The mission of CWBK’s experienced medical teams – doctors and nurses – is to ensure patients have access to modern forms of treatment, improving their health and quality of life, while maintaining the highest global standards of safety and respect for patient rights. The medical staff at CWBK is supported by a team of qualified administrative professionals experienced in managing medical and laboratory documentation in accordance with Good Clinical Practice (GCP) guidelines.

CWBK is actively involved in scientific and clinical initiatives with national and international research communities, paving the way for new projects, diagnostic methods, and future treatment solutions – namely, personalized medicine. The opportunity for these patients to participate in clinical trials not only opens access to drugs and therapies not financed by the National Health Fund (NFZ) but also reduces the cost of accessing and delivering treatment.

Verified
High Ratings
40+ Specializations
70+ Therapies
Research Phase I

About Specializations

Narodowy Instytut Geriatrii Reumatologii I Rehabilitacji Im Prof. Dr Hab. Med. Eleonory Reicher in Poland specializes in the clinical trials of conditions such as Androgenetic Alopecia, Atrial Fibrillation, Dermatomyositis and Polymyositis, and other specializations. This site conducts important res

Medical Center localisation

Ul. Spartanska 1
02-637 Warsaw, Poland
Show number

Want to learn more about this study or check if you can participate? Contact us.

Ongoing studies

  • Tulisokibart for Psoriatic Arthritis in Adults

    Recruiting

    Investigated drugs:
    Germany Poland Spain
  • A study testing RO7790121 for moderate to severe rheumatoid arthritis in patients who did not respond to or cannot tolerate TNF or JAK inhibitor treatments

    Recruiting

    Investigated drugs:
    Belgium Denmark France Germany Italy Poland +1
  • Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Bulgaria Croatia Czechia Denmark +17
  • Evaluation of nandrolone decanoate treatment combined with physiotherapy and diet in elderly patients with sarcopenia

    Recruiting

    1 1 1
    Poland
  • A study to evaluate the efficacy and safety of zenagamtide in people with overweight or obesity and knee osteoarthritis

    Recruiting

    1 1
    Investigated diseases:
    Bulgaria Denmark Greece Italy Poland Spain
  • A study to evaluate the effects of zenagamtide on weight and pain in patients with overweight or obesity and knee osteoarthritis

    Recruiting

    1 1
    Investigated diseases:
    Bulgaria Denmark Greece Italy Poland Spain
  • A study to evaluate the safety and effects of inebilizumab in children and adolescents with immunoglobulin G4-related disease

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Greece Italy Poland Spain
  • A study to evaluate the safety of dazodalibep in patients with Sjögren’s Syndrome over a long period of time

    Recruiting

    1 1 1
    Investigated diseases:
    Belgium Croatia Denmark France Germany Greece +6
  • Long-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis

    Recruiting

    1 1 1 1
    Belgium Bulgaria Czechia Denmark France Germany +6
  • A Study Testing Imeroprubart for Adults with Primary Sjogren’s Disease with Moderate to Severe Symptoms

    Recruiting

    Investigated diseases:
    Investigated drugs:
    Germany Greece Hungary Italy Poland Romania +1